The rationale for decision aids is addressed in the accompanying paper. Unlike hormone replacement therapy, prostate surgery is a "Rubicon" procedure -- that is, once undertaken it cannot be reversed. In the United States, a pilot study on the impact of a programme to aid in decisions about benign prostatic hyperplasia showed a 40% decrease in surgery rates. This finding was not replicated in a subsequent randomised controlled trial.
Posted in Patient Decision Aids, Patient Involvement, Special Populations
Tagged Angela Coulter, benign prostatic hyperplasia, BMJ, BPH, decision aids, decision-making, men, multimedia, primary care, prostatectomy, Shared Decision-Making® programs, treatment decisions
Most prostate cancers that are discovered after a PSA test are early-stage cancers. But not all early-stage cancers are the same. To understand how much treatment may help, it's important for men to understand whether their cancer is high or low risk. Then they can balance the benefit of treatment against the possible side effects. To help men make a good treatment decision, the Foundation has developed a Shared Decision-Making® program called Treatment Choices for Prostate Cancer.